Effect of Total Compression Time and Rate (Slope) on Incidence of Symptomatic ETD and MEB: A Phase II Prospective Study.
NCT04776967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2021-08-19
Summary
Eustachian tube dysfunction (ETD) and middle ear barotrauma (MEB) are common reported complications during hyperbaric oxygen treatment. The Phase I study data was the first to demonstrate a statistically significant decrease in the occurrence of symptomatic ETD and middle ear barotrauma (MEB). The Phase I Trial suggested the total time interval and rate (slope) of compression (ROC) may be a determining factor in ETD and MEB. This Phase II study investigates an optimal total time interval and rate of compression to reduce ETD and MEB when considering each multiplace treatment (with multiple patients) as the unit of observation collectively as a group, rather than for each individual patient.
Data will be collected prospectively on group patient-treatment exposures. The investigators randomly assigned patient-treatment group exposures to four different time interval and rate (slope) of compression. These total time intervals of compression and rates (slopes) of compression are identical to those used in the Phase I trial. All patients experiencing symptoms of ETD and MEB requiring compression stops will be evaluated post treatment to confirm the presence of ETD and MEB using the O'Neill Grading System (OGS). Data will be analyzed using the IBM-SPSS statistical software program.
The number of compression holds observed in each of the 4 compression schedules, similar to ther Phase I trial will be recorded. Patients who are symptomatic and require compression stops (as in the Phase I trial) using a United States Navy Treatment Table 9 (USN-TTN9) during elective hyperbaric oxygen treatments in a Class A multiplace hyperbaric chamber will be analyzed. Analysis using descriptive and inferential statistics will be applied to the patients requiring first stops in the 4 compression profiles. This Phase II study increases the sample size of treatments and they will be combined with the total number of treatments used in the original phase I study. This will increase power to facilitate detailed descriptive analysis and to determine if the findings are robust in the phase I study.
Conditions
- Eustachian Tube Dysfunction
- Middle Ear Barotrauma
- Middle Ear Disease
- Middle Ear; Injury
- Pressure Injury
- Ear Barotrauma
Interventions
- PROCEDURE
-
Hyperbaric Compression Profile
A total of 4 randomized hyperbaric treatment compression profiles (accepted standards of care) will be alternated over the patients course of treatment on a daily basis daily to the prescribed treatment depth.
Sponsors & Collaborators
-
Northwell Health
lead OTHER
Principal Investigators
-
Owen J O'Neill, MD, MPH · Phelps Hospital Northwell Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-08
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- United States
Study Locations
More Related Trials
-
The Accuracy of Sonotubometry to Assess the Eustachian Tube
NCT05740384 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Precision and Accuracy Using the Teed Scoring System Versus the O'Neill Grading System
NCT04726306 ·Status: ENROLLING_BY_INVITATION
-
Correlation Between the Degree of Middle Ear Pressure and the Eustachian Tube Dimensions : Radiological Study
NCT07343713 ·Status: NOT_YET_RECRUITING
-
Prediction & Mechanisms of Recovery Following IEDS
NCT06370897 ·Status: NOT_YET_RECRUITING
-
Efficacy of Balloon Dilation of the Eustachian Tube in Eustachian Tube Dilatory Dysfunction
NCT05719207 ·Status: RECRUITING ·Phase: NA
-
Middle Ear Pressure Disregulation After Tympanostomy Tube Insertion
NCT00393900 ·Status: COMPLETED
-
Eustachian Tube Testing in a Pressure Chamber -- Validation Study
NCT00694486 ·Status: COMPLETED
-
Gas Supply, Demand and Middle Ear Gas Balance -- Preliminary Protocol
NCT01955486 ·Status: COMPLETED ·Phase: NA
-
Eustachian Tube Dysfunction Assessment
NCT02667301 ·Status: COMPLETED ·Phase: NA
-
Balloon Dilation in Selected Subjects With Refractory Eustachian Tube Dysfunction
NCT02114762 ·Status: COMPLETED ·Phase: NA
-
Tubomanometry and EarPopper Devices for Eustachian Tube Function Testing
NCT03850197 ·Status: COMPLETED
-
Evaluation of Remote Fitting in Adult and Pediatric Users of the HiResolution Bionic Ear System
NCT05034731 ·Status: COMPLETED
-
Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss
NCT06729632 ·Status: RECRUITING ·Phase: NA
-
Ph.D.-Project: Eustachian Tube Dysfunction: Causes, Diagnosis, Treatment, and Prognosis
NCT05055115 ·Status: RECRUITING ·Phase: NA
-
The Accuracy of Tests of Eustachian Tube Function
NCT02385175 ·Status: COMPLETED
-
Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11
NCT00365092 ·Status: COMPLETED ·Phase: NA
-
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
NCT02283216 ·Status: WITHDRAWN ·Phase: NA
-
Noninvasive Therapy for Tinnitus
NCT07071480 ·Status: RECRUITING ·Phase: NA
-
Eustachian Tube Function and Myringoplasty/Tympanoplasty
NCT01766856 ·Status: TERMINATED
-
Risk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults
NCT01251432 ·Status: COMPLETED
-
Balloon Dilation of the Eustachian Tube, a Lower Pressure Challenge
NCT03322579 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Solo Tympanostomy Tube Device (TTD)
NCT02957578 ·Status: UNKNOWN ·Phase: NA
-
In This Study, we Are Testing Whether Combining Two Interventions, in the Early Stages of Tinnitus, is More Effective in Quieting Tinnitus Than Using One Treatment Alone in the Later Stages of Tinnitus
NCT07128004 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Balloon Eustachian Tuboplasty in Treatment of Chronic Eustachian Tube Dysfunction
NCT03556215 ·Status: COMPLETED ·Phase: NA
-
Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease
NCT00222417 ·Status: UNKNOWN